Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Activated Complement Components of Drusen Promote Choroidal Neovascularization

J.Z. Baffi; M. Nozaki; B.J. Raisler; E. Sakurai; K. Zhang; J.D. Lambris; J.V. Sarma; A. Humbles; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):860.

ARVO Annual Meeting Abstract May 2006

CCR3 Blockade Suppresses Experimental Choroidal Neovascularization

A. Takeda; M. Nozaki; B.J. Raisler; J.Z. Baffi; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1529.

ARVO Annual Meeting Abstract May 2006

Soluble Flt Is Essential for Corneal Avascularity: Biochemical and Comparative Anatomical Studies

B.K. Ambati; N. Singh; P. Jani; R. Caldwell; K. Smith; M. Nozaki; B. Raisler; D. Samuelson; A. Orecchia; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1600.

ARVO Annual Meeting Abstract May 2006

Corneal Avascularity Is Due to Soluble VEGF Receptor–1

R. Albuquerque; B. Raisler; M. Nozaki; J.Z. Baffi; A. Takeda; J.M. Collinson; L.J. Leiper; S. Ikeda; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1628.

ARVO Annual Meeting Abstract May 2006

The Anti–Angiogenic Activity of Vegf–A Is Masked by the Silencing of Vegfr–1 By Sparc

B.J. Raisler; M. Nozaki; J.Z. Baffi; V. Chandrasekaran; E.W. Taylor; R. Brekken; E.H. Sage; A. Ahmed; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1830.

ARVO Annual Meeting Abstract May 2006

VEGF–A Suppresses Choroidal Neovascularization via HO–1

J. Ambati; M. Nozaki; E. Sakurai; J.Z. Baffi; A. Takeda; B.J. Raisler; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1831.

ARVO Annual Meeting Abstract May 2005

Excess Endogenous VEGF–A Suppresses Laser–induced Choroidal Neovascularization via VEGFR–1

M. Nozaki; E. Sakurai; B.J. Raisler; J.Z. Baffi; M. Shibuya; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):470.

ARVO Annual Meeting Abstract May 2005

Drusen Complement Components C3a and C5a Promote Choroidal Neovascularization

B.J. Raisler; E. Sakurai; M. Nozaki; J.Z. Baffi; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1214.

ARVO Annual Meeting Abstract May 2005

Effect of 10% Dextran on Posterior Membrane Dystrophic and Pseudophakic Bullous Corneas

M.R. Patel; N. Desai; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2724.

ARVO Annual Meeting Abstract May 2005

Inhibition of Choroidal Neovascularization by VEGF–A Blockade Is Mediated via Ccl–2 Suppression

E. Sakurai; M. Nozaki; B.J. Raisler; J.Z. Baffi; Y. Ogura; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3027.

ARVO Annual Meeting Abstract May 2005

PLGF–1 Induces Corneal Neovascularization by Silencing Soluble VEGFR–1

J.Z. Baffi; M. Nozaki; J. Witta; B.J. Raisler; S. De Falco; M. Shibuya; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4494.

ARVO Annual Meeting Abstract May 2005

In situ Ablation of sFLT Disrupts the Corneal Anti–Angiogenic Barrier

B.K. Ambati; N. Singh; J. Witta; M. Nozaki; J.Z. Baffi; B. Raisler; S. Rashid; T. Suthar; A. Orecchia; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4501.

ARVO Annual Meeting Abstract May 2005

Pro– and Anti–Angiogenic Actions of VEGF–A are Differentially Routed via VEGFR–1 and VEGFR–2 Through SPARC Switching

J. Ambati; M. Nozaki; E. Sakurai; B.J. Raisler; J.Z. Baffi; R.A. Brekken; E.H. Sage; M. Shibuya; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4755.

ARVO Annual Meeting Abstract May 2004

Inhibition of VEGF Expression by VEGF RECEPTOR–1 Intrakine

S. Amin; N. Singh; E. Macnamara; A. Patel; J. Ambati; Z. Dong; J. Wang; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4818.

ARVO Annual Meeting Abstract May 2004

Phenylephrine Induces Fewer Higher–Order Aberrations Than Other Cycloplegic Agents

M.R. Patel; J.C. E. Wilson; N. Desai; D. Bogorad; L. Kano; P. Hanks; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):165.

ARVO Annual Meeting Abstract May 2004

Induction of Eotaxin–3 Expression in Human Retinal Pigmented Epithelial Cells by TNF– and VEGF–A.

J.Z. Baffi; E. Sakurai; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1804.

ARVO Annual Meeting Abstract May 2004

Soluble Flt–1 is present in human vitreous and is upregulated in patients with rhegmatogenous retinal detachment.

D.W. Skufca; J.Z. Baffi; A. Anand; S.J. Hasan; E. Sakurai; P.A. Pearson; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2053.

ARVO Annual Meeting Abstract May 2004

Targeted disruption of macrophage recruitment chemokines and chemokine receptors inhibits choroidal neovascularization.

E. Sakurai; J.Z. Baffi; B.K. Ambati; W.A. Kuziel; B.J. Rollins; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2227.

ARVO Annual Meeting Abstract May 2004

RNA interference can block VEGF upregulation in hypoxic corneal epithelial cells

B.K. Ambati; N. Singh; E. Macnamara; S. Amin; A. Patel; Z. Dong; J. Wang; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2347.

ARVO Annual Meeting Abstract May 2004

An animal model of atrophic and neovascular age–related macular degeneration in Ccl2–/– or Ccr2–/– mice

J. Ambati; A. Anand; E. Sakurai; S. Fernandez; B.J. Rollins; W.A. Kuziel; B.C. Lynn; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3388.

1 2

Next 20 Results »

Advertisement